481 related articles for article (PubMed ID: 19246252)
1. European best practice guidelines for cystic fibrosis neonatal screening.
Castellani C; Southern KW; Brownlee K; Dankert Roelse J; Duff A; Farrell M; Mehta A; Munck A; Pollitt R; Sermet-Gaudelus I; Wilcken B; Ballmann M; Corbetta C; de Monestrol I; Farrell P; Feilcke M; Férec C; Gartner S; Gaskin K; Hammermann J; Kashirskaya N; Loeber G; Macek M; Mehta G; Reiman A; Rizzotti P; Sammon A; Sands D; Smyth A; Sommerburg O; Torresani T; Travert G; Vernooij A; Elborn S
J Cyst Fibros; 2009 May; 8(3):153-73. PubMed ID: 19246252
[TBL] [Abstract][Full Text] [Related]
2. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
[TBL] [Abstract][Full Text] [Related]
5. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
7. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
Tluczek A; Koscik RL; Farrell PM; Rock MJ
Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
[TBL] [Abstract][Full Text] [Related]
10. Understanding newborn screening system issues with emphasis on cystic fibrosis screening.
Therrell BL; Lloyd-Puryear MA; Mann MY
J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785
[TBL] [Abstract][Full Text] [Related]
11. Sweat testing infants detected by cystic fibrosis newborn screening.
Parad RB; Comeau AM; Dorkin HL; Dovey M; Gerstle R; Martin T; O'Sullivan BP
J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
[TBL] [Abstract][Full Text] [Related]
12. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
[TBL] [Abstract][Full Text] [Related]
13. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
Lewis S; Curnow L; Ross M; Massie J
J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
[TBL] [Abstract][Full Text] [Related]
14. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
Dankert-Roelse JE; Mérelle ME
J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
[TBL] [Abstract][Full Text] [Related]
15. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
Wilfond BS; Parad RB; Fost N
J Pediatr; 2005 Sep; 147(3 Suppl):S109-13. PubMed ID: 16202773
[TBL] [Abstract][Full Text] [Related]
16. [Mucoviscidosis screening with immunoreactive trypsin].
Eber E; Ellemunter H; Engele H; Götz M; Grünberger W; Haas J; Janisch H; Leodolter S; Litscher H; Müller G
Wien Klin Wochenschr; 1992; 104(22):681-5. PubMed ID: 1475973
[TBL] [Abstract][Full Text] [Related]
17. Screening for cystic fibrosis in dried blood spots of newborns.
Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
[TBL] [Abstract][Full Text] [Related]
18. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.
Vernooij-van Langen AM; Loeber JG; Elvers B; Triepels RH; Gille JJ; Van der Ploeg CP; Reijntjens S; Dompeling E; Dankert-Roelse JE;
Thorax; 2012 Apr; 67(4):289-95. PubMed ID: 22271776
[TBL] [Abstract][Full Text] [Related]
19. Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening.
Sermet-Gaudelus I; Mayell SJ; Southern KW;
J Cyst Fibros; 2010 Sep; 9(5):323-9. PubMed ID: 20605539
[TBL] [Abstract][Full Text] [Related]
20. Thirty-years of screening for cystic fibrosis in East Anglia.
Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
